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Abstract Calcium phosphates (CaPs), extensively used
synthetic bone graft substitutes, are often combined with
other materials with the aim to overcome issues related to
poor mechanical properties of most CaP ceramics. Thin
ceramic coatings on metallic implants and polymer-ce-
ramic composites are examples of such hybrid materials.
Both the properties of the CaP used and the method of
incorporation into a hybrid structure are determinant for the
bioactivity of the final construct. In the present study, a
monolithic composite comprising nano-sized CaP and
poly(lactic acid) (PLA) and a CaP-coated PLA were
comparatively investigated for their ability to support
proliferation and osteogenic differentiation of bone mar-
row-derived human mesenchymal stromal cells (hMSCs).
Both, the PLA/CaP composite, produced using physical
mixing and extrusion and CaP-coated PLA, resulting from
a biomimetic coating process at near-physiological condi-
tions, supported proliferation of hMSCs with highest rates
at PLA/CaP composite. Enzymatic alkaline phosphatase
activity as well as the mRNA expression of bone mor-
phogenetic protein-2, osteopontin and osteocalcin were
higher on the composite and coated polymer as compared
to the PLA control, while no significant differences were
observed between the two methods of combining CaP and
PLA. The results of this study confirmed the importance of
CaP in osteogenic differentiation while the exact properties
and the method of incorporation into the hybrid material
played a less prominent role.
1 Introduction
To overcome issues related to the use of natural bone grafts
[1, 2] and to satisfy a rapidly increasing need for successful
and affordable strategies to treat damaged and diseased
bone tissue [2, 3], significant efforts are currently invested
in developing synthetic alternatives to natural bone. While
all three main material types, i.e. metals, ceramics and
polymers, as well as their combinations have been used as
bone graft substitutes, calcium phosphate (CaP) ceramics,
varying in chemistry (hydroxyapatite, tricalcium phos-
phate, brushite, octacalcium phosphate, etc.) [4] and mode
of application (sintered bulk ceramics, particles,
injectable cements, etc.) [5, 6] are the most widely used
materials, owing to their chemical resemblance to bone
mineral [7]. CaPs possess excellent biocompatibility in
osseous environment [1, 2, 5, 8], and more importantly,
they are generally accepted as osteoconductive materials
[9, 10], with a subpopulation even being osteoinductive
[11–13]. CaPs, however, suffer from intrinsic brittleness,
which is an important limiting factor, particularly in load-
bearing applications [14, 15]. To overcome this issue, CaP
ceramics have been combined with other materials, in
particular polymers, in the bulk [14–25] or as surface
coatings [8, 26]. For example, CaPs have been used to
develop monolithic composites with poly(a-esters) such as
poly(lactic acid) (PLA), poly(glycolic acid) (PGA) and
their copolymers (PLGA) [17–20], protein based polymers
including collagen [21] and gelatin [22, 23], polysaccha-
rides like chitosan [24] as well as synthetic co-polymers
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such as poly(ethylene oxide terephthalate)/poly(butylene
terephtalate) (PEOT-PBT) [25]. Alternatively to conven-
tional composites, physical assembly of the individual
components [25] has been used to develop polymer-ce-
ramic hybrids. Concerning coating techniques, classical
methods for coating CaPs on substrates, such as plasma-
spraying, have mainly been used to coat non-degradable
permanent metallic implants to improve their bioactivity
[8, 26–29], for example in total hip arthroplasty. Never-
theless, examples of more subtle coating techniques exist,
which are suitable for coating thermally less stable mate-
rials including polymers, such as biomimetic coating pro-
cess [30–32], radio frequency (RF) magnetron sputtering
[33], or pulse laser deposition [34].
Properties of a hybrid material, as well as its biological
performance, are dependent on the properties of each of the
components, as well as on the way they are combined. For
example, degradation of a CaP/polymer composite depends
on the physico-chemical properties of the ceramic (CaP
phase, crystallinity, surface area, etc.), physico-chemical
properties of the polymer (composition, molecular weight,
level of crosslinking etc.) as well as the way they are
integrated into the final product (solvent-based mixing,
physical mixing, coating, etc.).
In the current study, we hypothesized that direct contact
between the CaP component of a CaP/polymer hybrid
material and the biological environment is beneficial for
the bioactivity of the hybrid. To test this, we have produced
PLA particles and coated them with a thin layer of CaP by
immersion into a saturated CaP solution, and compared
them to composite particles produced by the extrusion of a
PLA/nano-sized CaP mixture. Upon characterization of
both particle types, bone marrow-derived human mes-
enchymal stromal cells (hMSCs) were cultured on the two
materials, followed by the assessment of their proliferation
and differentiation towards the osteogenic lineage.
2 Materials and methods
2.1 Materials production
For this study, two hybrid materials consisting of CaP and
PLA were produced: a monolithic PLA/CaP composite and
a CaP-coated PLA. PLA without CaP served as control.
The composite consisted of 50 wt% amorphous poly(D,L-
lactic acid) (PLA) (Purasorb PDL05, Purac, MW:
59000 g mol-1) and 50 wt% nano-sized CaP apatite
powder, prepared in-house using a wet precipitation
method as was described previously [18–20]. Briefly, the
HA was precipitated in a mixture of aqueous solutions of
(NH4)2HPO4 and Ca(NO3)24H2O at a pH above 10. The
resulting precipitate was allowed to age overnight, washed
and finally resuspended in acetone and allowed to dry. The
composite was produced by extrusion using a twin-screw
extruder with conical non-converging screws (Artecs BV,
Enschede, The Netherlands). The PLA and CaP powder
were mixed for 5 min in the extruder at 150 C using the
screw rotation speed of 100 rpm. The composite was
extruded in the form of rods, which were ground and sieved
to obtain composite particles in the range of 0.5–1 mm.
PLA particles were obtained using the same procedure
of extrusion, grinding and sieving as described above for
the PLA/CaP composite. The particles were either left
uncoated or were coated with a CaP layer via a two-step
biomimetic method similar to the one described earlier [35,
36]. In short, the particles were first immersed in a con-
centrated Simulated Body Fluid (SBF 2.5x) with ionic
content of 733.5 mM Na2?, 7.5 mM Mg2?, 12.5 mM
Ca2?, 720 mM Cl-, 5 mM HPO4
2- and 21 mM HCO3
-,
under stirring at 37 C for 3 days, with daily refreshment.
In the second step, the particles were incubated with a
calcium phosphate solution (CPS) consisting of 140 mM
Na2?, 4 mM Ca2?, 2 mM HPO4
2- and 144 mM Cl-
(buffered at pH 7.4), while stirring at 37 C for 3 days with
two refreshments. The coated PLA particles were then
washed three times with MilliQ water and dried at least
overnight in an air oven at 37 C.
2.2 Material characterization
The surface morphology and elemental analysis of calcium,
phosphorous and carbon were investigated on gold-sput-
tered PLA, PLA/CaP composite and CaP-coated PLA
particles using scanning electron microscopy (SEM, XL-30
ESEM-FEG, Philips) in the secondary electron mode,
coupled with energy dispersive X-ray spectroscopy ana-
lyzer (EDS, EDAX, AMETEK Materials Analysis Divi-
sion) at the accelerator voltage of 10 keV and working
distance of 10 mm. The chemical composition of various
particles was characterized using Fourier transform infra-
red spectroscopy (FTIR, Perkin-Elmer Spectrum 1000) in
transmission mode and X-ray diffraction method (XRD,
PANaltytical X’Pert). Thermogravimetric analysis (TGA,
STA 449 F3, NETZSCH) was performed in the tempera-
ture range of 35–1000 C and the weight loss was calcu-
lated to determine the mineral content.
The release of Ca2? and inorganic phosphate (Pi) ions
from different particles was analyzed in simulated physi-
ological solution (SPS) containing 137 mmol L-1 Na?,
177 mmol L-1 Cl-, 50 mmol L-1 HEPES in MilliQ water
and buffered at pH 7.3 over a period of 3 months.
100 ± 1 mg of PLA, PLA/CaP composite or CaP-coated
PLA particles were precisely weighed and immersed in
5 ml SPS in plastic tubes. The tubes were then placed in a
shaking water bath at 37 C. At dedicated time points
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between 1 and 12 weeks, triplicates of each sample were
removed from water bath and Ca2? and Pi ion content of
SPS was quantified using QuantiChromTM Calcium assay
kit (DICA-500, BioAssay Systems, USA) and Quan-
tiChromTM Phosphate assay kit (DIPI-500 BioAssay Sys-
tems, USA), respectively, according to manufacturer’s
protocols.
2.3 In vitro cell culture
hMSCs were isolated from bone marrow aspirates
(5–20 ml) after written informed consent, as described
previously [37, 38]. Briefly, aspirates were resuspended
using 20-gauge needles, plated at a density of 5 9 105 cells
per cm2, and cultured in proliferation medium (consisting
of a-MEM (Gibco) supplemented with 10 v/v % fetal
bovine serum (Lonza), 2 mM L-glutamine (Gibco),
0.2 mM ascorbic acid (Sigma), 62.69 lg ml-1 penicillin,
100 lg ml-1 streptomycin (Gibco) and 1 ng ml-1 rhbFGF
(AbDSerotec)). The medium was refreshed every
2–3 days. Cells were harvested at approximately 80 %
confluency for subculture until passage 3.
In an earlier study, hMSCs that were isolated and
expanded using this method were shown to be positive for
CD29, CD44, CD105, and CD166 which are typical
markers of hMSCs, and to possess the potential to differ-
entiate into the osteogenic lineage in vitro and to induce
new bone formation in vivo [38].
Approximately 100 ll of particles were placed in the
wells of non plasma-treated 25-well plates with square-
shaped bottom and sterilized with isopropanol prior to cell
culture. To sterilize, the samples were washed three times
with 100 % isopropanol followed by 15 min of drying
inside the flow cabinet after each washing step. In the last
step of sterilization, 100 % isopropanol was added to the
samples and allowed to evaporate in the flow cabinet for at
least 2 h. The samples were then washed twice with sterile
PBS, followed by an overnight incubation in 1 ml basic
medium (proliferation medium without rhbFGF) in a
humidified atmosphere at 37 C and 5 % CO2.
The particles were then collected in one corner of the
wells and 200,000 hMSCs of passage 3 were seeded on the
particles in approximately 50 ll of basic cell culture
medium. This seeding method and density were optimized
based on a preliminary study (data not shown). To maxi-
mize the attachment of the cells on the particles, the wells
were tilted and cells were allowed to attach for 4 h. 1 ml of
either basic medium or osteogenic medium (basic medium
supplemented with 10 nM dexamethasone (Sigma)) was
added to each well. The medium was refreshed every
3–4 days. Old medium was collected at each refreshment
and the concentration of Ca2? was determined using
QuantiChromTM calcium assay kit.
Total DNA amount was assessed with CyQuant Cell
Proliferation Assay kit (Invitrogen) at day 7 and 14 after
washing the samples with PBS. After 3 freeze/thaw cycles
at -80 C, 500 ll lysis buffer (lysis buffer provided in the
kit diluted in a buffer of NaCl-EDTA solution) was added
to each well. The samples were ultra-sonicated and incu-
bated at RT for 1 h. After centrifugation, 100 ll of the
supernatant was mixed with the same volume of CyQuant
GR dye in a 96 well micro-plate and incubated for 15 min.
Fluorescence measurements for DNA quantification were
performed at excitation and emission wavelengths of 480
and 520 nm, respectively, using a spectrophotometer
(Perkin Elmer). ALP activity in the cultures was measured
using a CDP-star kit (Roche Applied Science). 10 ll of
the supernatant was mixed with 40 ll CDP-star reagent in
a 96 well micro-plate and incubated for 30 min. After
incubation, chemiluminescence measurements were
Table 1 Primer sequences of
the osteogenic genes, the




GAPDH (housekeeping gene) 50-CCATGGTGTCTGAGCGATGT
50-CGCTCTCTGCTCCTCCTGTT
Alkaline phosphatase (ALP) 50-TTCAGCTCGTACTGCATGTC
50-ACAAGCACTCCCACTTCATC
Runt-related transcription factor 2 (RUNX2) 50-GGAGTGGACGAGGCAAGAGTTT
50-AGCTTCTGTCTGTGCCTTCTGG
Bone sialoprotein (BSP) 50-TCCCGTTCTCACTTTCATA
50-CCCCACCTTTTGGGAAAAC
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completed at 466 nm. Results of the DNA assays are
presented based on average lg of DNA detected in each
condition. Results of ALP activity were normalized for
DNA content of each culture and presented as the average
of normalized ALP activity per lg of DNA for each
condition.
Total RNA was isolated by using a combination of
NucleoSpin RNA II isolation kit and Trizol method, in
accordance with the manufacturer’s protocol. RNA was
collected in RNAse-free water and the total concentration
was measured using nano-drop equipment (ND1000 spec-
trophotomer, Thermo Scientific). The cDNA of the cultures
were then prepared using iScript kit (Bio-Rad) according to
the manufacturer’s protocol and diluted 10 times in
RNAse-free water to be used for quantitative real-time
PCR (qPCR). The qPCR measurements were completed
using Bio-Rad equipment using Syber green I master mix
(Invitrogen) and the primer sequences (Sigma), which are
listed in Table 1. Expression of the osteogenic marker
genes was normalized to GAPDH levels and fold induction
was calculated by using the DDCT method. mRNA level of
the desired genes in hMSCs cultured on treated tissue
culture plates (TCPs) at the density of 10,000 cells cm-2 in
basic cell culture medium for 7 days was also quantified
and used for normalizing the results.
2.4 Statistical analysis
Statistical comparisons were performed using One-way
Analysis of Variance (ANOVA) followed by a Tukey’s
multiple comparison post hoc test. Error bars indicate one
standard deviation. The level of significance was set at
P\ 0.05.
3 Results
3.1 Characterization of the hybrid materials
Particles of both pure PLA and of the two hybrid materials
were dense with an irregular shape and with a size ranging
between 0.5 and 1 mm (Fig. 1a1–c1). While the surface of
pure PLA appeared smooth (Fig. 1b1), PLA/CaP compos-
ite particles exhibited a more rough surface structure
(Fig. 1b2). CaP-coated PLA particles were homogenously
covered with a coating consisting of small plate-shaped
crystals, giving it a rough surface morphology (Fig. 1b3).
The EDS spectrum of PLA particles exhibited only
carbon (C) and oxygen (O) peaks (Fig. 1a3). A reduction in
the intensity of C peak was observed in the EDS spectra of
both PLA/CaP composite and CaP-coated PLA particles
whereas the intensity of the O peak increased in these
samples. Moreover, the EDS spectra of the two hybrid
materials exhibited calcium and phosphorus peaks,
demonstrating the presence of a CaP phase in these sam-
ples (Fig. 1b3–c3). The EDS elemental maps confirmed
these results (Fig. 1a4–c6). A uniform distribution of cal-
cium and phosphorus were observed in the elemental maps
of composite and coated PLA particles showing a
homogenous distribution of CaP in the polymer matrix and
a uniform surface coating, respectively.
The FTIR spectra and the XRD patterns of the PLA,
PLA/CaP composite and CaP-coated PLA are shown in
Fig. 2. The spectrum of PLA showed peaks at approxi-
mately 1000–1100 cm-1, corresponding to stretching
mode of C-O bond. The peaks of C–H bond in bending and
stretching modes were observed at approximately
1370–1450 and 1950–2000 cm-1, respectively. A single
peak that appeared at 1750 cm-1 is attributed to stretching
mode of C=O bond [39, 40]. The PLA spectrum was in
agreement with previously published data [18].
All peaks, typical of the PLA chemistry, were also found
in the FTIR spectra of the two hybrid materials. A new
band was observed around 1000 cm-1, probably due to the
presence of PO4
3-, the band of which appears at the similar
wavelength [18, 19]. The bands at 560 and 604 cm-1 in the
FTIR spectra of CaP-containing particles are also attributed
to the P–O bond. Moreover, the hydroxyl bands at 635 and
3565 cm-1 were detected in the spectrum of PLA/CaP
composite suggesting the apatitic phase [18, 19]. In the
spectrum of the CaP-coated PLA, the hydroxyl band at
3565 cm-1 appeared as a small shoulder on the H2O band.
The XRD pattern of PLA particles did not show any
distinguishable peaks, confirming the amorphous nature of
the polymer. The XRD pattern of the PLA/CaP composite
was in accordance with those obtained in previous studies,
showing the presence of pure crystalline hydroxyapatite
(HA) phase [18, 19]. The most intense diffraction lines at
2theta = 26, 31.9, 32.2, 33, 34.2, 29.9, 46.9 and 49.5, are
attributed (002), (211), (112), (300), (202), (130), (222),
and (213) crystalline planes in HA [41]. The XRD pattern
of CaP-coated PLA showed less intense and broader peaks
compared to the one of the composite material, confirming
the formation of a less crystalline CaP phase. The most
intense peak was observed at approximately 4.9, which is
bFig. 1 SEM images at low (a1, b1, c1) and high (a2, b2, c2)
magnification, EDS spectra (a3, b3, c3), carbon- (a4, b4, c4),
calcium- (a5, b5, c5) and phosphorus (a6, b6, c6) elemental map of
PLA, PLA/CaP composite and CaP-coated PLA, respectively. The
PLA particles exhibited smooth surface, while the surface of the PLA/
CaP composite appeared rougher with a homogenous distribution of
CaP powder within the PLA matrix. A uniform CaP layer consisting
of small, plate-shaped crystals was observed on PLA-coated particles.
It should be noted that gold (Au) peak was observed in all the EDS
spectra because the samples were gold-sputtered before SEM/EDS
analysis
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attributed (010) crystalline plane of octacalcium phosphate
(OCP). The small peak found at 25.9 corresponds to (002)
plane in both OCP and HA structure [41, 42]. The broad
peak at about 32 is normally seen in the XRD pattern of
OCP with a rather low intensity. The relatively high
intensity of the peak at about 32 suggests the presence of
an apatitic phase.
The TGA analysis (Fig. 3), performed in the tempera-
ture range 35–1000 C, showed a single drop in weight for
all materials. The weight loss occurred in the approximate
temperature range of 300–400 C and was calculated to be
98.9, 56 and 93.8 % for PLA, PLA/CaP composite and
CaP-coated PLA particles, respectively.
Cumulative release of Ca2? and Pi ions over a period of
12 weeks was investigated upon immersion of polymeric
and hybrid particles in CPS (Fig. 4a, b). A slight release of
Ca2? was measured in the solutions containing PLA par-
ticles at 1, 2, 3, and 6 weeks, possibly accidentally intro-
duced to the solution during preparation, while no Pi ions
were detected at any of the time points. A constant Ca2?
release to a maximum level of 200 lM was detected for
PLA/CaP composite particles until week 3, after which a
decrease to a concentration approximately 150 lM was
observed. A linear increase in Pi ion concentration of PLA/
CaP containing CPS was observed up to week 9, reaching a
maximum concentration of 100 lM. At week 12, the Pi ion
level substantially decreased to 60 lM. For the CaP-coated
particles, an increasing release of Ca2? up to 180 lM was
observed until week 2. This concentration remained con-
stant for another week, and then linearly decreased to
approximately 100 lM at week 12. The Pi ion release
profile of CaP-coated polymer showed an increase in
concentration to 110 lM in week 3, followed by a drop to
approximately 80 lM in the remaining experimental
period.
The Ca2? concentration in time was also examined in
the cell culture medium over a 2-week period to inves-
tigate to which ionic concentrations the cells are exposed
during culture (Fig. 4c). The Ca2? concentration of the
cell culture medium not containing any materials varied
in the range of 1.7–2.0 mM over the 2-week period.
Similar to the medium without materials, the Ca2? con-
centration of the PLA-incubated medium showed varia-
tions in the range of 1.8–2.1 mM. A substantial decrease
to approximately 300 lM was detected in Ca2? concen-
tration after immersion of PLA/CaP composite particles in
cell culture medium for 4 days, followed by a gradual
increase to 600 lM, at day 14. A slight decrease of
approximately 200 lM was observed in the Ca2? con-
centration of the medium containing CaP-coated PLA
particles at the first time point, a concentration that was
comparable to that of the medium not containing any
material. The Ca2? level then increased in time, up to
2.5 mM at day 14.
Fig. 2 FTIR spectra (a) and XRD patterns (b) of the PLA, PLA/CaP
and CaP-coated PLA particles. The FTIR spectra of the two hybrid
materials exhibited additional bands demonstrating the presence of
CaP. The XRD patterns suggested the presence of a crystalline HA in
the composite and a mixture of OCP and apatite in the coated PLA
Fig. 3 The TGA graphs showing weight loss of (a) PLA, (b) PLA/CaP and (c) CaP-coated PLA in the temperature range 35–1000 C. A weight
loss of 98.9, 56 and 93.8 % were measured for PLA, PLA/CaP and CaP-coated PLA, respectively
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3.2 Response of hMSCs to hybrid materials
The DNA content of the hMSCs cultured on the PLA and
the two hybrid samples was quantified at days 7 and 14
(Fig. 5a). At day 7, the DNA content of cells cultured on
PLA/CaP composite was slightly higher as compared to
PLA and CaP-coated PLA conditions in both media,
however, the only significant difference was found between
PLA/CaP composite and PLA particles, in osteogenic
medium. At day 14, hMSCs cultured on CaP-coated PLA
particles showed slightly higher DNA content compared to
those cultured on PLA particles in both media, although
this difference was not statistically significant. hMSCs
cultured on composite, however, showed significantly
higher DNA content compared to those cultured on PLA
and coated PLA particles, both in basic and osteogenic
medium. While only small, non-significant temporal
increase in the DNA content of hMSCs cultured on PLA
and coated PLA was observed, the DNA content of hMSCs
cultured on PLA/CaP composite particles increased 3–4
times between days 7 and 14.
ALP activity of the hMSCs was also quantified and
normalized for the DNA content (Fig. 5b). At day 7, in
both basic and osteogenic medium, both PLA/CaP
composite and CaP-coated PLA samples showed higher
ALP activity compared to PLA, however, this effect was
significant only between CaP-coated PLA and PLA. ALP
activity of hMSCs cultured on CaP-coated PLA was
slightly higher than when the cells were cultured on PLA/
CaP composite. At day 14, in basic medium, ALP activity
measured on CaP-coated PLA was measured to be higher,
although not significantly, than what was found on PLA
and PLA/CaP composite samples. In osteogenic medium,
both hybrid materials showed a significantly higher ALP
activity than the pure polymer.
The mRNA expression of a panel of osteogenic markers
including ALP, RUNX2, BSP, BMP2, OP and OC by
hMSCs cultured on the three material types in either basic or
osteogenic medium was analyzed after 7 and 14 days
(Fig. 6a–f). No significant differences in the ALP mRNA
expression were observed among cells cultured on different
materials, except at day 14 in basic medium, where PLA
particles exhibited a higher ALP mRNA level as compared
to the two hybrid materials. In general, the expression of the
ALP gene was low at both time points and in both media, not
exceeding a 1.5-fold change. At day 7, a significantly higher
level of RUNX2 mRNA was measured on CaP-coated PLA
as compared to PLA particles without CaP in osteogenic
Fig. 4 The Ca2? (a) and Pi ion (b) concentrations in SPS and the
Ca2? (c) concentration in cell culture medium upon immersion of
PLA, PLA/CaP and CaP-coated PLA particles. Both hybrid materials
enriched the SPS solution with Ca2? and Pi ions at earlier time points,
followed by a slight decrease of concentrations of both ions at later
time points. Immersion of CaP-coated PLA in cell culture medium
resulted in an initial decrease of Ca2? concentration, which was
recovered at later time points. PLA/CaP composite particles depleted
cell culture medium of the Ca2? ions, at all time points analyzed
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medium, while no differences were found at day 14. At both
time points, the expression of BMP2 and OP was higher in
the hMSCs cultured on the two CaP-containing materials as
compared to the cells cultured on PLA particles in basic
medium. mRNA level of these two markers in osteogenic
medium was in general low, however, a significant differ-
ence was observed in the expression of BMP2 between CaP-
coated PLA and PLA particles at day 7. The mRNA level of
OC was also higher in hMSCs cultured on CaP-containing
particles compared to those cultured on PLA particles at
both time points and in both media, although the only sig-
nificant difference was observed between CaP-coated PLA
and PLA particles at day 7 in basic medium.
4 Discussion
In a search for successful synthetic alternatives to natural
bone grafts, hybrid biomaterials are developed in which
desired properties of the individual components are
combined. In the current study, we have compared two
hybrid materials consisting of CaP and PLA and investi-
gated whether the method of combining the two, affects the
response of hMSCs. While CaPs are widely used as bone
graft substitutes owing to their resemblance to bone min-
eral [7] and related biocompatibility and bioactivity [1],
polymers offer more diversity when it comes to mechanical
properties [15–17].
An amorphous PLA with a relatively low molecular
weight was selected for this study. PLA, being an aliphatic
polyester, degrades by hydrolysis and the degradation
profile of the polymeric phase has been shown to affect the
degradation of hybrid materials, such as PLA/CaP com-
posites [18]. Barbieri et al. [20] studied the role of the PLA
molecular weight on mechanical and physicochemical
properties of PLA/HA composite, similar to the one used in
this study, as well as on their bone forming ability in vivo.
The results revealed a higher fluid uptake by the composite
prepared using low molecular weight PLA, resulting in
release of more Ca2? and Pi ions from and faster degra-
dation of the composite. Moreover, heterotopic bone for-
mation, or osteoinduction, which is considered an
important characteristic of bone grafts and their substitutes,
was only detected in the composites prepared with low
molecular weight PLA.
To prepare monolithic composite in the current study,
equal amounts of nano-sized CaP powder and PLA were
mixed and extruded, a method that allowed preparation of a
homogenous composite with a relatively high ceramic
content. The TGA results demonstrated a mass loss of
56 % in the composite material within the temperature
range of 200–300 C. Within this temperature range, the
organic component of the composite is expected to be
completely thermally degraded and removed. No signifi-
cant mass loss was observed at higher temperatures, indi-
cating a total ceramic content to be 44 %, which correlated
well with the initial HA/PLA weight ratio used to produce
the composite material. CaP content of PLA/CaP com-
posites has been shown to substantially influence the
mechanical properties of the composite [43–45]. On the
other hand, the CaP content is also a critical factor deter-
mining degradation rate, bioactivity and bone forming
ability of the composite, showing that indeed the properties
of the individual components determine the properties of
the hybrid material. Results of intramuscular implantation
of PLA/HA composites with HA content varying from 0 to
40 wt% in dogs showed that heterotopic bone formation
only occurred in the composite containing 40 wt% of HA
[19]. Heterotopic bone formation was also observed upon
implantation of HA/PLA composite with weight ratio of
50/50 prepared by extrusion technique in sheep and dog
in vivo models, while no bone formation was observed in
PLA control implants [18, 20].
Fig. 5 DNA content (a) and ALP activity (b) of hMSCs cultured on
PLA, PLA/CaP and CaP-coated PLA particles. DNA content of
hMSCs cultured on PLA/CaP particles was higher than that of hMSCs
cultured on CaP-coated PLA and PLA particles. The ALP activity of
the hMSCs was enhanced when cultured on the two hybrid materials
as compared to the PLA control. Asterisk symbol indicates P\ 0.05
when compared to PLA/CaP composite and plus symbol indicates
P\ 0.05, when compared to CaP-coated PLA
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A biomimetic method, involving immersion of poly-
meric particles into a solution containing Ca2? and Pi ions
under near-physiological conditions was used to deposit a
homogenous layer on the polymer surface that was a
mixture of OCP and apatite. Both these phases are bio-
logically relevant, with carbonated apatite closely resem-
bling the composition of bone mineral [7] and OCP being
suggested as a precursor of biological apatite in hard tissue
Fig. 6 mRNA expression of ALP (a), RUNX2 (b), BSP (c), BMP2
(d), OP (e) and OC (f) in hMSCs cultured on PLA, PLA/CaP and
CaP-coated PLA particles. Minor differences were detected in the
mRNA expression of ALP, RUNX2 and BSP in hMSCs cultured on
different materials. In contrast, the expression of BMP2, OP and OC
genes was substantially higher in hMSCs cultured on PLA/CaP and
CaP-coated PLA particles in comparison with PLA particles, in
particular in basic cell culture medium. Hash symbol indicates
P\ 0.05 when compared to PLA, asterisk symbol indicates P\ 0.05
when compared to PLA/CaP composite and plus symbol indicates
P\ 0.05, when compared to CaP-coated PLA
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[46]. Both phases are also less stable than hydroxyapatite,
showing a faster dissolution at neutral pH values [47]. In
contrast to a relatively high CaP content of the monolithic
composite, the TGA data showed that in CaP-coated par-
ticles, the mineral phase represented only 6.2 wt%.
Interestingly, despite this large difference in total min-
eral content between the two hybrid materials, upon
immersion in SPS, a buffered solution, both materials
showed a maximum release of approximately 200 lM and
100 lM of Ca2? and Pi ions, respectively. Nevertheless,
this concentration was more rapidly reached in CaP-coated
PLA than in PLA/CaP composite, which can be related to
both difference in CaP phase and the higher exposure of the
CaP phase to the solution. While in the CaP-coated PLA,
all CaP is on the surface, in the composite material, the
majority of the mineral is in the bulk, and release of ions is
dependent on the polymer degradation and the diffusion of
the ions through the material bulk. In contrast to what was
observed in SPS that, as-prepared, does not contain Ca2? or
Pi ions, in cell culture medium, a direct decrease of Ca2?
concentration was observed upon immersion of PLA/CaP
composite particles or CaP-coated PLA particles, plausibly
suggesting precipitation of a new CaP phase as was
observed previously [48].
Regarding the differences in response of hMSCs to the
two hybrid materials, with PLA without CaP as a control,
cell proliferation on PLA/CaP composite particles was
higher as compared to PLA. Previous results have shown
that supplementing cell culture medium with 4, 7.8 or
8 mM Ca2? increased the DNA content of hMSCs cultured
on tissue culture plastic [49, 50], suggesting a positive
effect of Ca2? ions on hMSCs proliferation. In one of our
previous studies [18], extruded PLA and PLA-HA com-
posite with similar characteristics as used here were casted
into pellets with a smooth surface. In contrast to the present
study, no differences in proliferation of hMSCs were
observed between the polymer and composite material,
which may be due to differences in total surface area
between a 2D pellet and a 3D environment of a collection
of particles. Furthermore, differences between the two
studies could, for at least in a part, be caused by the
physical differences between materials, such as the
observed surface roughness.
Besides differences in proliferation of hMSCs as a result
of presence of CaP, differences were also observed
dependent on the method used to combine the polymer and
the ceramic phase. Cells cultured on PLA/CaP composite
particles had a higher DNA content as compared to those
cultured on CaP-coated PLA particles. Both differences in
the chemical composition and topographical properties
between these two materials may be responsible for this
effect. This is in accordance with previous studies showing
a more pronounced osteoblast attachment to an HA surface
as compared to an OCP surface. Besides the difference in
chemical composition and degradation properties, these
two materials exhibited different grain size, which could
also be of influence on cell attachment [51].
The ALP activity of hMSCs cultured on either PLA/CaP
composite or CaP-coated PLA was higher as compared to
that of cells cultured on PLA particles. Similarly, other
studies also demonstrated a higher ALP activity of various
cell types when cultured on PLA/CaP composite materials
prepared using different techniques, in comparison with the
polymer not containing the mineral phase [18, 52–54].
Furthermore, Kim et al. [55] and Kung et al. [56] also
observed that the ALP activity of bone marrow- and adi-
pose-derived mesenchymal stem cells cultured on fibrous
PLA meshes, the surface of which was covered with CaP,
was significantly higher as compared to the culture on PLA
samples without the ceramic. Danoux et al. [50] observed
that the addition of 4 or 8 lM Ca2?, or 4 lM Pi ions to the
cell culture medium enhanced the ALP activity of hMSCs.
Furthermore, it was also shown that the individual release
of these ions from only calcium-containing or only phos-
phate-containing PLA particles increased the ALP activity
of hMSCs compared to pure PLA particles. These results
suggested that both Ca2? and Pi ions released from the
particles were responsible for promoting ALP activity in
hMSCs.
Surprisingly, no effect of the hybrid materials on the
mRNA level of ALP was detected, which may be explained
by a transient peak expression of mRNA, in contrast to
proteins, which are more stable. Similar to ALP, RUNX2
and BSP genes were not influenced at mRNA level when
the cells were cultured on different types of particles.
The expression of BMP2, OP and OC genes was sub-
stantially increased in hMSCs cultured on the PLA/CaP
composite and CaP-coated PLA particles as compared to
those cultured on PLA particles not containing CaP. These
findings are in line with previously published studies,
where the presence of CaP on electrospun PLA meshes had
a positive effect on the expression of osteogenic markers
such as collagen type I, OC and OP on stem cells from
different origin [55, 56]. Furthermore, it was previously
shown that the expression of BMP2, OP and OC markers
wee significantly enhanced at elevated Ca2? levels [49,
50]. Although the Ca2? level in the cell culture medium
was shown to decrease in the presence of CaP-containing
particles, it should be noted that the ionic concentration
was measured in the bulk medium, not taking into account
possible concentration differences between the bulk and
the medium in close vicinity of the particle surface where
cells are found, where Ca2? concentration may be higher.
Furthermore, apart from this chemical effect, the effect of
physical surface properties of these materials, like rough-
ness, surface area, etc. on differentiation of hMSCs should
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not be neglected, although these effects were not separately
studied here.
No significant differences were observed in the expres-
sion of the osteogenic markers between hMSCs cultured on
PLA/CaP composite and those cultured on CaP-coated
PLA. The two hybrid materials differed in several prop-
erties including the phase, the amount and the availability
in the CaP component, as well as the physical surface
properties, which, taken together, resulted in a more pro-
nounced decrease in concentration of Ca2? and, expectedly
Pi ions in cell culture medium in the case of the monolithic
composite as compared to the CaP-coated PLA. These
differences however, were not reflected in the differentia-
tion potential of hMSCs when cultured on the different
materials suggesting that both methods of combining PLA
and CaP can be used to enhance the osteogenic differen-
tiation of hMSCs as compared to PLA without CaP.
5 Conclusion
The results of the current study confirmed the beneficial
effect of CaP regarding the osteogenic differentiation of
hMSCs. This effect was independent of the method used to
combine the CaP and the PLA component into a hybrid
material, i.e. generation of a monolithic composite or
coating of the polymer with a ceramic layer.
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